Kako mogu izbjeći nadraživanje ili preosjetljivost kože koju uzrokuje ljepilo podloge senzora?
Ova razmatranja, zaštitna barijera kože i profesionalni savjeti mogu vam pomoći. Ne zaboravite da ono što je dobro za jednu osobu ne mora biti dobro za svakoga. Vi i vaš zdravstveni stručnjak možda ćete trebati isprobavati nekoliko različitih proizvoda ili metoda kako biste shvatili koja vam od ovih opcija najviše odgovara.
Opća razmatranja*
- Kožu očistite antimikrobnim sapunom bez ulja i dobro je osušite1,2
- Za masnu kožu preporučuje se blagi piling2
- Prema potrebi, dlake obrijte suhom britvicom3
- Na mjestu umetanja senzora ne koristite nikakav losion ili ulje koje sadrži sredstvo za hidrataciju
- Senzor nemojte umetati odmah nakon tuširanja/kupanja ili u kupaonici punoj vodene pare – vlagu smanjite smanjite sušilom za kosu na najmanju moguću mjeru ili ga na postavite u suhom okruženju2
- Dezodorans u obliku sticka ili spreja (bez mirisa) može pomoći ako je koža sklona znojenju. Dezodoransom oblikujte praznu ovalnu površinu na koži, pričekajte 10 do 15 minuta. Senzor umetnite na čistu kožu na sredinu ovalne površine.1,2
Zaštitni filmovi*
- Zaštitni filmovi mogu spriječiti nastanak blaga nadraživanja kože izazvanih ljepilima4
- Dezodoransom oblikujte praznu ovalnu površinu na zaštitnom filmu i umetnite senzor na čistu kožu na sredinu ovalne površine
- Ostavite da se zaštitni film potpuno osuši prije postavljanja senzora1,4
- Mogu li nanijeti 1 sloj ili drugi nakon što se prvi sloj osušio?
- Zaštitni filmovi sami po sebi mogu djelovati nadražujuće i možda neće spriječiti prodiranje alergena u kožu
Zaštitni filmovi*
- Zaštitne flastere i zavoje koristite samo ako vam zaštitni film nije pomogao
- Tvrtka Dexcom nije testirala upotrebu zaštitnih flastera i zavoja. Sa svojim zdravstvenim stručnjakom razgovarajte o upotrebi flastera i zavoja.
- Kada se koriste kao zaštita, flasteri/zavoji moraju se staviti ispod ljepljive podloge senzora1,5,6
- Stavite ih na kožu prije podloge senzora • Izrežite ovalni otvor na flasteru/zavoju i umetnite senzor na čistu kožu na sredinu ovalnog otvora
*Messer, L. , & Beatson, C., Preserving Skin Integrity with Chronic Device Use in Diabetes. Technology & Therapeutics Volume 20, Supplement 2, 2018.
† Kamann, S., Heinemann, L., & Oppel, E., Usage of Hydrocolloid-Based Plasters in Patients Who Have Developed Allergic Contact Dermatitis to Isobornyl Acrylate While Using Continuous Glucose Monitoring Systems. Journal of Diabetes Science and Technology, 2019.
‡ Paret, M., Barash, G. & Rachmiel, M. “Out of the box” solution for skin problems due to glucose-monitoring technology in youth with type 1 diabetes: real-life experience with fluticasone spray. Acta Diabetol 57, 419–424 (2020).
1. Ives B, Sikes K, Urban A, et al.: Practical aspects of realtime continuous glucose monitors: the experience of the Yale Children’s Diabetes Program. Diabetes Educ 2010;36: 53–62.
2. Chase HP, Messer L: Understanding Insulin Pumps and Continuous Glucose Monitors. 3rd ed. Denver: Children’s Diabetes Research Foundation, 2016.
3. Karlin AW, Ly TT, Pyle L, et al.: Duration of infusion set survival in lipohypertrophy versus nonlipohypertrophied tissue in patients with type 1 diabetes. Diabetes Technol Ther 2016;18:429–435.
4. McNichol L, Lund C, Rosen T, Gray M: Medical adhesives and patient safety: State of the science: consensus statements for the assessment, prevention, and treatment of adhesiverelated skin injuries. J Wound Ostomy Continence Nurs 2013;40:365–380; quiz E361–E362.
5. Englert K, Ruedy K, Coffey J, et al.: Skin and adhesive issues with continuous glucose monitors: a sticky situation. J Diabetes Sci Technol 2014;8:745–751. a Used within institution or support in public commentary, online articles, diabetes blogs, social media.
† Kamann, S., Heinemann, L., & Oppel, E., Usage of Hydrocolloid-Based Plasters in Patients Who Have Developed Allergic Contact Dermatitis to Isobornyl Acrylate While Using Continuous Glucose Monitoring Systems. Journal of Diabetes Science and Technology, 2019.
‡ Paret, M., Barash, G. & Rachmiel, M. “Out of the box” solution for skin problems due to glucose-monitoring technology in youth with type 1 diabetes: real-life experience with fluticasone spray. Acta Diabetol 57, 419–424 (2020).
1. Ives B, Sikes K, Urban A, et al.: Practical aspects of realtime continuous glucose monitors: the experience of the Yale Children’s Diabetes Program. Diabetes Educ 2010;36: 53–62.
2. Chase HP, Messer L: Understanding Insulin Pumps and Continuous Glucose Monitors. 3rd ed. Denver: Children’s Diabetes Research Foundation, 2016.
3. Karlin AW, Ly TT, Pyle L, et al.: Duration of infusion set survival in lipohypertrophy versus nonlipohypertrophied tissue in patients with type 1 diabetes. Diabetes Technol Ther 2016;18:429–435.
4. McNichol L, Lund C, Rosen T, Gray M: Medical adhesives and patient safety: State of the science: consensus statements for the assessment, prevention, and treatment of adhesiverelated skin injuries. J Wound Ostomy Continence Nurs 2013;40:365–380; quiz E361–E362.
5. Englert K, Ruedy K, Coffey J, et al.: Skin and adhesive issues with continuous glucose monitors: a sticky situation. J Diabetes Sci Technol 2014;8:745–751. a Used within institution or support in public commentary, online articles, diabetes blogs, social media.
LBL021329 Rev001